No Data
Lineage Cell Therapeutics Analyst Ratings
Trump Media Saw the Largest Increase in Short Interest in October
Lineage Cell Therapeutics Entered Into Definitive Agreements With Certain Institutional Investors And With Broadwood Partners, L.P. For The Purchase And Sale Of Up To An Aggregate Of 39,473,688 Of Lineage's Common Shares And Accompanying Warrants To...
Express News | Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Wells Fargo Maintains Lineage(LINE.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)
No Data
No Data
